Cart
sales@molnova.com
UCCF-853
CAS No. 625458-06-2
UCCF-853( —— )
Catalog No. M34455 CAS No. 625458-06-2
UCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 107 | In Stock |
|
| 25MG | 180 | In Stock |
|
| 50MG | 263 | In Stock |
|
| 100MG | 390 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUCCF-853
-
NoteResearch use only, not for human use.
-
Brief DescriptionUCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis.
-
DescriptionUCCF-853 is a CFTR modulator.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCFTR
-
RecptorCFTR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number625458-06-2
-
Formula Weight312.67
-
Molecular FormulaC14H8ClF3N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC2=CC(=CC=C2N1C=3C=CC=C(Cl)C3)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nicoletta Pedemonte, et al. Influence of cell background on pharmacological rescue of mutant CFTR. Am J Physiol Cell Physiol. 2010 Apr;298(4):C866-74.?
molnova catalog
related products
-
WAY-326766
WAY-326766 increases ion transport through mutant CFTR and can be used to alter the lifespan of eukaryotes.WAY-326766 can be used to treat cystic fibrosis (CF).
-
IOWH-032
A novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays for the treatment of cystic fibrosis; potentially serves as lead compound for development of new drugs for the treatment of cystic fibrosis.
-
GLPG-2222
GLPG-2222 (ABBV-2222, Galicaftor)?is a novel potent and efficacious CFTR corrector with EC50 of 5 nM; is highly potent (5 nM) and efficacious in cells from multiple CF patient donors that have F508del homozygous mutation.
